# Axillary Lymph Node Tattoo Marking Study

> **NCT04947917** · NA · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer
- Lymph Node Metastases

## Interventions

- **PROCEDURE:** SpotTM Tattoo Ink

## Key facts

- **NCT ID:** NCT04947917
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-29
- **Primary completion:** 2023-04-13
- **Final completion:** 2023-04-13
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Institutional standard of care regarding axillary management changed. Decision was made to close the study early.
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947917, "Axillary Lymph Node Tattoo Marking Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04947917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*